ADMA vs. SE
ADMA (ADMA Biologics, Inc.) and SE (Sea Limited) are both stocks. ADMA operates in Biotechnology (Healthcare), while SE operates in Electronic Gaming & Multimedia (Communication Services). Over the past 5 years, ADMA returned 35.16%/yr vs -21.47%/yr for SE. At a 0.20 correlation, their price movements are largely independent.
Performance
ADMA vs. SE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ADMA achieves a -54.99% return, which is significantly lower than SE's -34.98% return.
ADMA
- 1D
- -1.32%
- 1M
- -3.41%
- YTD
- -54.99%
- 6M
- -58.49%
- 1Y
- -61.99%
- 3Y*
- 27.09%
- 5Y*
- 35.16%
- 10Y*
- 1.84%
SE
- 1D
- -3.21%
- 1M
- -11.31%
- YTD
- -34.98%
- 6M
- -33.66%
- 1Y
- -46.36%
- 3Y*
- 8.08%
- 5Y*
- -21.47%
- 10Y*
- —
ADMA vs. SE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | -54.99% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | 12.24% |
SE Sea Limited | -34.98% | 20.24% | 161.98% | -22.16% | -76.74% | 12.39% | 394.90% | 255.30% | -15.08% | -17.97% |
Correlation
The correlation between ADMA and SE is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2017 | 0.20 |
The correlation between ADMA and SE shifts across timeframes, from 0.07 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ADMA:
$1.97B
SE:
$52.76B
ADMA:
$0.68
SE:
$2.57
ADMA:
12.13
SE:
32.21
ADMA:
3.93
SE:
2.06
ADMA:
5.05
SE:
4.11
ADMA:
$509.86M
SE:
$25.19B
ADMA:
$312.42M
SE:
$11.15B
ADMA:
$218.74M
SE:
$2.33B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADMA vs. SE — Risk / Return Rank
ADMA
SE
ADMA vs. SE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Sea Limited (SE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ADMA | SE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.22 | ||
| Sortino ratioReturn per unit of downside risk | -0.44 | ||
| Omega ratioGain probability vs. loss probability | 0.76 | 0.83 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.98 | -0.77 | -0.21 |
| Martin ratioReturn relative to average drawdown | -1.95 | -1.27 | -0.68 |
Loading charts...
Drawdowns
ADMA vs. SE - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, roughly equal to the maximum SE drawdown of -90.51%. Use the drawdown chart below to compare losses from any high point for ADMA and SE.
Loading charts...
Drawdown Indicators
| ADMA | SE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.28% | -90.51% | -0.77% |
Max Drawdown (1Y)Largest decline over 1 year | -63.48% | -60.22% | -3.26% |
Max Drawdown (3Y)Largest decline over 3 years | -68.99% | -60.22% | -8.77% |
Max Drawdown (5Y)Largest decline over 5 years | -68.99% | -90.51% | +21.52% |
Max Drawdown (10Y)Largest decline over 10 years | -86.11% | — | — |
Current DrawdownCurrent decline from peak | -66.50% | -77.40% | +10.90% |
Average DrawdownAverage peak-to-trough decline | -53.05% | -44.10% | -8.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.85% | 36.57% | -2.72% |
Volatility
ADMA vs. SE - Volatility Comparison
The current volatility for ADMA Biologics, Inc. (ADMA) is 9.74%, while Sea Limited (SE) has a volatility of 14.69%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than SE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADMA | SE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.74% | 14.69% | -4.95% |
Volatility (6M)Calculated over the trailing 6-month period | 45.54% | 38.05% | +7.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.60% | 50.74% | +3.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.47% | 64.13% | -4.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.03% | 62.59% | +6.44% |
Dividends
ADMA vs. SE - Dividend Comparison
Neither ADMA nor SE has paid dividends to shareholders.
Financials
ADMA vs. SE - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Sea Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ADMA vs. SE - Profitability Comparison
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
SE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sea Limited reported a gross profit of 3.15B and revenue of 7.10B. Therefore, the gross margin over that period was 44.3%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
SE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sea Limited reported an operating income of 565.39M and revenue of 7.10B, resulting in an operating margin of 8.0%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
SE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sea Limited reported a net income of 427.94M and revenue of 7.10B, resulting in a net margin of 6.0%.
Frequently Asked Questions
ADMA and SE have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SE has higher volatility (14.69%) compared to ADMA (9.74%). In terms of maximum drawdown, ADMA dropped -91.28% vs SE's -90.51%.
SE currently has the higher Sharpe Ratio (-0.92 vs -1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ADMA and SE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer